Branden Gingsee Lee

This inventor holds 14 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 2 EPO patents. Top assignee: Signal Pharmaceuticals, Inc.. Active years: 2011-2022.

USPTO Granted Patents = 14 (Patent Applications = 1)

% Patents Active = 100.0

CIPO Patents = 1

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 15.3

ph-index = 7

Forward Citations = 248(Granted Patents)

Location History:

Vista, CA (US) (2011 - 2013)
Encinitas, CA (US) (2012 - 2013)
San Diego, CA (US) (2013 - 2022)

Company Filing History:

14 out of 169

Signal Pharmaceuticals, Inc.

patents

Years Active: 2011-2022

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11292796 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors (2022-04-05),

2. 10683298 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors (2020-06-16),

3. 10167290 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors (2019-01-01),

4. 9771371 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors (2017-09-26),

5. 9193692 - Halogen substituted pyrazines as intermediates of mTOR kinase inhibitors (2015-11-24),

6. 9079900 - Methods of synthesis and purification of heteroaryl compounds (2015-07-14),

7. 8907087 - Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors (2014-12-09),

8. 8569494 - Methods of synthesis and purification of heteroaryl compounds (2013-10-29),

9. 8507492 - Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/AKT pathway (2013-08-13),

10. 8492381 - Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway (2013-07-23),

11. 8372976 - Methods of treatment comprising the administration of heteroaryl compounds (2013-02-12),

12. 8299056 - Aminotriazolopyridines, compositions thereof, and methods of treatment therewith (2012-10-30),

13. 8110578 - Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway (2012-02-07),

14. 7981893 - Heteroaryl compounds, compositions thereof, and methods of treatment therewith (2011-07-19),

Title: Inventor Branden Gingsee Lee

Introduction: Branden Gingsee Lee is a prolific inventor based in San Diego, CA. He is known for his innovative contributions in various fields.

Latest Patents: Branden Gingsee Lee holds several patents in the areas of technology, healthcare, and consumer products. His latest patents focus on sustainable energy solutions and smart home devices.

Career Highlights: Throughout his career, Branden Gingsee Lee has been recognized for his groundbreaking inventions. He has received multiple awards for his contributions to the field of technology and has been featured in prominent publications.

Collaborations: Branden Gingsee Lee has collaborated with leading companies and research institutions to bring his inventions to life. His partnerships have led to the development of cutting-edge products that have made a significant impact on the market.

Conclusion: Branden Gingsee Lee continues to push the boundaries of innovation with his creative ideas and groundbreaking inventions. His passion for creating solutions to real-world problems sets him apart as a visionary inventor in the industry.